Teva

(Image: Getty/Kevron2001)

FDA aims to speed naloxone generics to market

By Ben Hargreaves

US FDA follows up the first generic approval of naloxone nasal spray by encouraging companies to apply with generic applications amid the North American opioid crisis.

(Image: Getty/greenleaf123)

FDA greenlights nine Lyrica generics

By Vassia Barba

Nine companies, including Teva, Alembic and Amneal receive US FDA approval for generic versions of Pfizer’s blockbuster Lyrica.

(Image: Getty/Bedo)

The most read stories in March

By Staff Reporter

After the M&A excitement that began the year, the developments in March were a mixture of long-running events, such as the sartan manufacturing issues, breakthrough research and regulatory struggles.